Tecnimede
Tecnimede, founded in 1980, was the Group's first company and the one that gave it its name.
Ever since its inception, Tecnimede has always been defined by its dynamic approach and has been recognised as a partner by all healthcare professionals.
With a focus on new products, the company's offering includes a portfolio of prescription medications and innovative products, thereby contributing to the well-being of the community and the improvement of the quality of life of the general public.
Tecnimede is also known for the support it provides with regard to scientific training. The Tecnishare platform is an example of this, which is aimed at healthcare professionals, providing them with access to varied useful content to assist them in their day-to-day work.
Main Therapeutic Areas
Tecnimede has made its mark in the main therapeutic areas, through a broad portfolio of prescription medications and innovative products.
Cardiometabolic Health
According to the Organisation for Economic Co-operation and Development (OECD), cardiovascular diseases, such as Hypertension or Diabetes, remain the primary causes of death in OECD countries.
Women's and Men's Health
Women's and Men's Health are two of Tecnimede's core therapeutic areas, with a portfolio directed to diseases such as Genitourinary Syndrome of Menopause, Urinary Incontinence, or Benign Prostate Hyperplasia.
Pharmacovigilance
Find out here how to proceed in the event of issues relating to safety or to report a possible adverse event related to Tecnimede products.